Simplex Trading’s Apollo Endosurgery APEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-500
Closed -$4K – 10608
2022
Q4
$4K Buy
+500
New +$3.73K ﹤0.01% 8310
2022
Q2
– Sell
-15,400
Closed -$93K – 11549
2022
Q1
$93K Buy
15,400
+12,900
+516% +$78.6K ﹤0.01% 6263
2021
Q4
$21K Buy
2,500
+2,300
+1,150% +$20.1K ﹤0.01% 8336
2021
Q3
$1K Hold
200
– – ﹤0.01% 9711
2021
Q2
$1K Buy
+200
New +$1.37K ﹤0.01% 9889
2015
Q1
– Hold
0
– -$2K – 5791
2014
Q4
– Hold
0
– – – 3862

Simplex Trading's APEN Position: Q2 2022 in Review

Simplex Trading sold out of Apollo Endosurgery (APEN) in Q2 2022, closing a stake of 8,470 shares — an estimated $40K sold.

Simplex Trading first reported a position in APEN in Q4 2014 and held it in 2 quarters. The position peaked at $51K in Q1 2022. 63 funds tracked by Wall St. Rank hold APEN as of Q2 2022.

  • Simplex Trading reported no remaining Apollo Endosurgery position as of Q2 2022 after selling out during the quarter.
  • Simplex Trading sold 8,470 Apollo Endosurgery shares in Q2 2022, an estimated $40K.
  • Simplex Trading first reported a position in Apollo Endosurgery in Q4 2014 and held it in 2 quarters.
  • Simplex Trading's Apollo Endosurgery position peaked at $51K in Q1 2022.
  • 63 funds tracked by Wall St. Rank held Apollo Endosurgery as of Q2 2022.

Based on Simplex Trading's 13F filing for Q2 2022, filed 3 Aug 2022.